ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lentiviral Vector In Gene Therapy Market Insights and Forecast to 2028
Published Date: February 2022
|
Report Code: QYRE-Auto-30V7563
Home | Market Reports | Science | Biological Sciences
Global Lentiviral Vector In Gene Therapy Market Insights and Forecast to 2028

Global Lentiviral Vector In Gene Therapy Market Insights and Forecast to 2028

Code: QYRE-Auto-30V7563
Report
February 2022
Pages:99
QYResearch
Description
Table of Content
Tables & Figures
FEATURED COMPANIES
Thermo Fisher Scientific Sirion-Biotech GmbH
Vigene Biosciences
Origene Technologies
SignaGen Laboratories
Takara Bio
Cell Biolabs
GenTarget
GENEMEDI
Bluebird bio
Market Analysis and Insights: Global Lentiviral Vector In Gene Therapy Market

Due to the COVID-19 pandemic, the global Lentiviral Vector In Gene Therapy market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Retrovirus (RV) accounting for % of the Lentiviral Vector In Gene Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital segment is altered to an % CAGR throughout this forecast period.
China Lentiviral Vector In Gene Therapy market size is valued at US$ million in 2021, while the US and Europe Lentiviral Vector In Gene Therapy are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Lentiviral Vector In Gene Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Lentiviral Vector In Gene Therapy include Thermo Fisher Scientific Sirion-Biotech GmbH, Vigene Biosciences, OriGene Technologies, SignaGen Laboratories, Takara Bio, Cell Biolabs, GenTarget, GENEMEDI and Bluebird Bio. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Lentiviral Vector In Gene Therapy Scope and Segment
Lentiviral Vector In Gene Therapy market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Lentiviral Vector In Gene Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Retrovirus (RV)
Adenovirus (AdV)
Adeno-associated Virus (AAV)

Segment by Application

Hospital
Clinic
Research Institution
Others

BY COMPANY

Thermo Fisher Scientific Sirion-Biotech GmbH
Vigene Biosciences
OriGene Technologies
SignaGen Laboratories
Takara Bio
Cell Biolabs
GenTarget
GENEMEDI
Bluebird Bio

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
FEATURED COMPANIES
Thermo Fisher Scientific Sirion-Biotech GmbH
Vigene Biosciences
Origene Technologies
SignaGen Laboratories
Takara Bio
Cell Biolabs
GenTarget
GENEMEDI
Bluebird bio
1 Study Coverage
1.1 Lentiviral Vector In Gene Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Lentiviral Vector In Gene Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Retrovirus (RV)
1.2.3 Adenovirus (AdV)
1.2.4 Adeno-associated Virus (AAV)
1.3 Market by Application
1.3.1 Global Lentiviral Vector In Gene Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institution
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Lentiviral Vector In Gene Therapy Sales Estimates and Forecasts 2017-2028
2.2 Global Lentiviral Vector In Gene Therapy Revenue Estimates and Forecasts 2017-2028
2.3 Global Lentiviral Vector In Gene Therapy Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Lentiviral Vector In Gene Therapy Sales by Region
2.4.1 Global Lentiviral Vector In Gene Therapy Sales by Region (2017-2022)
2.4.2 Global Sales Lentiviral Vector In Gene Therapy by Region (2023-2028)
2.5 Global Lentiviral Vector In Gene Therapy Revenue by Region
2.5.1 Global Lentiviral Vector In Gene Therapy Revenue by Region (2017-2022)
2.5.2 Global Lentiviral Vector In Gene Therapy Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Lentiviral Vector In Gene Therapy Sales by Manufacturers
3.1.1 Global Top Lentiviral Vector In Gene Therapy Manufacturers by Sales (2017-2022)
3.1.2 Global Lentiviral Vector In Gene Therapy Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lentiviral Vector In Gene Therapy in 2021
3.2 Global Lentiviral Vector In Gene Therapy Revenue by Manufacturers
3.2.1 Global Lentiviral Vector In Gene Therapy Revenue by Manufacturers (2017-2022)
3.2.2 Global Lentiviral Vector In Gene Therapy Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Lentiviral Vector In Gene Therapy Revenue in 2021
3.3 Global Lentiviral Vector In Gene Therapy Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Lentiviral Vector In Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Lentiviral Vector In Gene Therapy Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Lentiviral Vector In Gene Therapy Sales by Type
4.1.1 Global Lentiviral Vector In Gene Therapy Historical Sales by Type (2017-2022)
4.1.2 Global Lentiviral Vector In Gene Therapy Forecasted Sales by Type (2023-2028)
4.1.3 Global Lentiviral Vector In Gene Therapy Sales Market Share by Type (2017-2028)
4.2 Global Lentiviral Vector In Gene Therapy Revenue by Type
4.2.1 Global Lentiviral Vector In Gene Therapy Historical Revenue by Type (2017-2022)
4.2.2 Global Lentiviral Vector In Gene Therapy Forecasted Revenue by Type (2023-2028)
4.2.3 Global Lentiviral Vector In Gene Therapy Revenue Market Share by Type (2017-2028)
4.3 Global Lentiviral Vector In Gene Therapy Price by Type
4.3.1 Global Lentiviral Vector In Gene Therapy Price by Type (2017-2022)
4.3.2 Global Lentiviral Vector In Gene Therapy Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Lentiviral Vector In Gene Therapy Sales by Application
5.1.1 Global Lentiviral Vector In Gene Therapy Historical Sales by Application (2017-2022)
5.1.2 Global Lentiviral Vector In Gene Therapy Forecasted Sales by Application (2023-2028)
5.1.3 Global Lentiviral Vector In Gene Therapy Sales Market Share by Application (2017-2028)
5.2 Global Lentiviral Vector In Gene Therapy Revenue by Application
5.2.1 Global Lentiviral Vector In Gene Therapy Historical Revenue by Application (2017-2022)
5.2.2 Global Lentiviral Vector In Gene Therapy Forecasted Revenue by Application (2023-2028)
5.2.3 Global Lentiviral Vector In Gene Therapy Revenue Market Share by Application (2017-2028)
5.3 Global Lentiviral Vector In Gene Therapy Price by Application
5.3.1 Global Lentiviral Vector In Gene Therapy Price by Application (2017-2022)
5.3.2 Global Lentiviral Vector In Gene Therapy Price Forecast by Application (2023-2028)
6 North America
6.1 North America Lentiviral Vector In Gene Therapy Market Size by Type
6.1.1 North America Lentiviral Vector In Gene Therapy Sales by Type (2017-2028)
6.1.2 North America Lentiviral Vector In Gene Therapy Revenue by Type (2017-2028)
6.2 North America Lentiviral Vector In Gene Therapy Market Size by Application
6.2.1 North America Lentiviral Vector In Gene Therapy Sales by Application (2017-2028)
6.2.2 North America Lentiviral Vector In Gene Therapy Revenue by Application (2017-2028)
6.3 North America Lentiviral Vector In Gene Therapy Market Size by Country
6.3.1 North America Lentiviral Vector In Gene Therapy Sales by Country (2017-2028)
6.3.2 North America Lentiviral Vector In Gene Therapy Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Lentiviral Vector In Gene Therapy Market Size by Type
7.1.1 Europe Lentiviral Vector In Gene Therapy Sales by Type (2017-2028)
7.1.2 Europe Lentiviral Vector In Gene Therapy Revenue by Type (2017-2028)
7.2 Europe Lentiviral Vector In Gene Therapy Market Size by Application
7.2.1 Europe Lentiviral Vector In Gene Therapy Sales by Application (2017-2028)
7.2.2 Europe Lentiviral Vector In Gene Therapy Revenue by Application (2017-2028)
7.3 Europe Lentiviral Vector In Gene Therapy Market Size by Country
7.3.1 Europe Lentiviral Vector In Gene Therapy Sales by Country (2017-2028)
7.3.2 Europe Lentiviral Vector In Gene Therapy Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Lentiviral Vector In Gene Therapy Market Size by Type
8.1.1 Asia Pacific Lentiviral Vector In Gene Therapy Sales by Type (2017-2028)
8.1.2 Asia Pacific Lentiviral Vector In Gene Therapy Revenue by Type (2017-2028)
8.2 Asia Pacific Lentiviral Vector In Gene Therapy Market Size by Application
8.2.1 Asia Pacific Lentiviral Vector In Gene Therapy Sales by Application (2017-2028)
8.2.2 Asia Pacific Lentiviral Vector In Gene Therapy Revenue by Application (2017-2028)
8.3 Asia Pacific Lentiviral Vector In Gene Therapy Market Size by Region
8.3.1 Asia Pacific Lentiviral Vector In Gene Therapy Sales by Region (2017-2028)
8.3.2 Asia Pacific Lentiviral Vector In Gene Therapy Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Lentiviral Vector In Gene Therapy Market Size by Type
9.1.1 Latin America Lentiviral Vector In Gene Therapy Sales by Type (2017-2028)
9.1.2 Latin America Lentiviral Vector In Gene Therapy Revenue by Type (2017-2028)
9.2 Latin America Lentiviral Vector In Gene Therapy Market Size by Application
9.2.1 Latin America Lentiviral Vector In Gene Therapy Sales by Application (2017-2028)
9.2.2 Latin America Lentiviral Vector In Gene Therapy Revenue by Application (2017-2028)
9.3 Latin America Lentiviral Vector In Gene Therapy Market Size by Country
9.3.1 Latin America Lentiviral Vector In Gene Therapy Sales by Country (2017-2028)
9.3.2 Latin America Lentiviral Vector In Gene Therapy Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Lentiviral Vector In Gene Therapy Market Size by Type
10.1.1 Middle East and Africa Lentiviral Vector In Gene Therapy Sales by Type (2017-2028)
10.1.2 Middle East and Africa Lentiviral Vector In Gene Therapy Revenue by Type (2017-2028)
10.2 Middle East and Africa Lentiviral Vector In Gene Therapy Market Size by Application
10.2.1 Middle East and Africa Lentiviral Vector In Gene Therapy Sales by Application (2017-2028)
10.2.2 Middle East and Africa Lentiviral Vector In Gene Therapy Revenue by Application (2017-2028)
10.3 Middle East and Africa Lentiviral Vector In Gene Therapy Market Size by Country
10.3.1 Middle East and Africa Lentiviral Vector In Gene Therapy Sales by Country (2017-2028)
10.3.2 Middle East and Africa Lentiviral Vector In Gene Therapy Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Thermo Fisher Scientific Sirion-Biotech GmbH
11.1.1 Thermo Fisher Scientific Sirion-Biotech GmbH Corporation Information
11.1.2 Thermo Fisher Scientific Sirion-Biotech GmbH Overview
11.1.3 Thermo Fisher Scientific Sirion-Biotech GmbH Lentiviral Vector In Gene Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Thermo Fisher Scientific Sirion-Biotech GmbH Lentiviral Vector In Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Thermo Fisher Scientific Sirion-Biotech GmbH Recent Developments
11.2 Vigene Biosciences
11.2.1 Vigene Biosciences Corporation Information
11.2.2 Vigene Biosciences Overview
11.2.3 Vigene Biosciences Lentiviral Vector In Gene Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Vigene Biosciences Lentiviral Vector In Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Vigene Biosciences Recent Developments
11.3 OriGene Technologies
11.3.1 OriGene Technologies Corporation Information
11.3.2 OriGene Technologies Overview
11.3.3 OriGene Technologies Lentiviral Vector In Gene Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 OriGene Technologies Lentiviral Vector In Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 OriGene Technologies Recent Developments
11.4 SignaGen Laboratories
11.4.1 SignaGen Laboratories Corporation Information
11.4.2 SignaGen Laboratories Overview
11.4.3 SignaGen Laboratories Lentiviral Vector In Gene Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 SignaGen Laboratories Lentiviral Vector In Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 SignaGen Laboratories Recent Developments
11.5 Takara Bio
11.5.1 Takara Bio Corporation Information
11.5.2 Takara Bio Overview
11.5.3 Takara Bio Lentiviral Vector In Gene Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Takara Bio Lentiviral Vector In Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Takara Bio Recent Developments
11.6 Cell Biolabs
11.6.1 Cell Biolabs Corporation Information
11.6.2 Cell Biolabs Overview
11.6.3 Cell Biolabs Lentiviral Vector In Gene Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Cell Biolabs Lentiviral Vector In Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cell Biolabs Recent Developments
11.7 GenTarget
11.7.1 GenTarget Corporation Information
11.7.2 GenTarget Overview
11.7.3 GenTarget Lentiviral Vector In Gene Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 GenTarget Lentiviral Vector In Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GenTarget Recent Developments
11.8 GENEMEDI
11.8.1 GENEMEDI Corporation Information
11.8.2 GENEMEDI Overview
11.8.3 GENEMEDI Lentiviral Vector In Gene Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 GENEMEDI Lentiviral Vector In Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 GENEMEDI Recent Developments
11.9 Bluebird Bio
11.9.1 Bluebird Bio Corporation Information
11.9.2 Bluebird Bio Overview
11.9.3 Bluebird Bio Lentiviral Vector In Gene Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Bluebird Bio Lentiviral Vector In Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Bluebird Bio Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Lentiviral Vector In Gene Therapy Industry Chain Analysis
12.2 Lentiviral Vector In Gene Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Lentiviral Vector In Gene Therapy Production Mode & Process
12.4 Lentiviral Vector In Gene Therapy Sales and Marketing
12.4.1 Lentiviral Vector In Gene Therapy Sales Channels
12.4.2 Lentiviral Vector In Gene Therapy Distributors
12.5 Lentiviral Vector In Gene Therapy Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Lentiviral Vector In Gene Therapy Industry Trends
13.2 Lentiviral Vector In Gene Therapy Market Drivers
13.3 Lentiviral Vector In Gene Therapy Market Challenges
13.4 Lentiviral Vector In Gene Therapy Market Restraints
14 Key Findings in The Global Lentiviral Vector In Gene Therapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Thermo Fisher Scientific Sirion-Biotech GmbH
Vigene Biosciences
Origene Technologies
SignaGen Laboratories
Takara Bio
Cell Biolabs
GenTarget
GENEMEDI
Bluebird bio
List of Tables
    Table 1. Global Lentiviral Vector In Gene Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Retrovirus (RV)
    Table 3. Major Manufacturers of Adenovirus (AdV)
    Table 4. Major Manufacturers of Adeno-associated Virus (AAV)
    Table 5. Global Lentiviral Vector In Gene Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Lentiviral Vector In Gene Therapy Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Lentiviral Vector In Gene Therapy Sales by Region (2017-2022) & (K Units)
    Table 8. Global Lentiviral Vector In Gene Therapy Sales Market Share by Region (2017-2022)
    Table 9. Global Lentiviral Vector In Gene Therapy Sales by Region (2023-2028) & (K Units)
    Table 10. Global Lentiviral Vector In Gene Therapy Sales Market Share by Region (2023-2028)
    Table 11. Global Lentiviral Vector In Gene Therapy Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Lentiviral Vector In Gene Therapy Revenue Market Share by Region (2017-2022)
    Table 13. Global Lentiviral Vector In Gene Therapy Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Lentiviral Vector In Gene Therapy Revenue Market Share by Region (2023-2028)
    Table 15. Global Lentiviral Vector In Gene Therapy Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Lentiviral Vector In Gene Therapy Sales Share by Manufacturers (2017-2022)
    Table 17. Global Lentiviral Vector In Gene Therapy Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Lentiviral Vector In Gene Therapy Revenue Share by Manufacturers (2017-2022)
    Table 19. Lentiviral Vector In Gene Therapy Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 20. Global Lentiviral Vector In Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Lentiviral Vector In Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lentiviral Vector In Gene Therapy as of 2021)
    Table 22. Lentiviral Vector In Gene Therapy Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Lentiviral Vector In Gene Therapy Product Offered
    Table 24. Date of Manufacturers Enter into Lentiviral Vector In Gene Therapy Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Lentiviral Vector In Gene Therapy Sales by Type (2017-2022) & (K Units)
    Table 27. Global Lentiviral Vector In Gene Therapy Sales by Type (2023-2028) & (K Units)
    Table 28. Global Lentiviral Vector In Gene Therapy Sales Share by Type (2017-2022)
    Table 29. Global Lentiviral Vector In Gene Therapy Sales Share by Type (2023-2028)
    Table 30. Global Lentiviral Vector In Gene Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Lentiviral Vector In Gene Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Lentiviral Vector In Gene Therapy Revenue Share by Type (2017-2022)
    Table 33. Global Lentiviral Vector In Gene Therapy Revenue Share by Type (2023-2028)
    Table 34. Lentiviral Vector In Gene Therapy Price by Type (2017-2022) & (US$/Unit)
    Table 35. Global Lentiviral Vector In Gene Therapy Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 36. Global Lentiviral Vector In Gene Therapy Sales by Application (2017-2022) & (K Units)
    Table 37. Global Lentiviral Vector In Gene Therapy Sales by Application (2023-2028) & (K Units)
    Table 38. Global Lentiviral Vector In Gene Therapy Sales Share by Application (2017-2022)
    Table 39. Global Lentiviral Vector In Gene Therapy Sales Share by Application (2023-2028)
    Table 40. Global Lentiviral Vector In Gene Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Lentiviral Vector In Gene Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Lentiviral Vector In Gene Therapy Revenue Share by Application (2017-2022)
    Table 43. Global Lentiviral Vector In Gene Therapy Revenue Share by Application (2023-2028)
    Table 44. Lentiviral Vector In Gene Therapy Price by Application (2017-2022) & (US$/Unit)
    Table 45. Global Lentiviral Vector In Gene Therapy Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 46. North America Lentiviral Vector In Gene Therapy Sales by Type (2017-2022) & (K Units)
    Table 47. North America Lentiviral Vector In Gene Therapy Sales by Type (2023-2028) & (K Units)
    Table 48. North America Lentiviral Vector In Gene Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Lentiviral Vector In Gene Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Lentiviral Vector In Gene Therapy Sales by Application (2017-2022) & (K Units)
    Table 51. North America Lentiviral Vector In Gene Therapy Sales by Application (2023-2028) & (K Units)
    Table 52. North America Lentiviral Vector In Gene Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Lentiviral Vector In Gene Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Lentiviral Vector In Gene Therapy Sales by Country (2017-2022) & (K Units)
    Table 55. North America Lentiviral Vector In Gene Therapy Sales by Country (2023-2028) & (K Units)
    Table 56. North America Lentiviral Vector In Gene Therapy Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Lentiviral Vector In Gene Therapy Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Lentiviral Vector In Gene Therapy Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Lentiviral Vector In Gene Therapy Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Lentiviral Vector In Gene Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Lentiviral Vector In Gene Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Lentiviral Vector In Gene Therapy Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Lentiviral Vector In Gene Therapy Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Lentiviral Vector In Gene Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Lentiviral Vector In Gene Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Lentiviral Vector In Gene Therapy Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Lentiviral Vector In Gene Therapy Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Lentiviral Vector In Gene Therapy Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Lentiviral Vector In Gene Therapy Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Lentiviral Vector In Gene Therapy Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Lentiviral Vector In Gene Therapy Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Lentiviral Vector In Gene Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Lentiviral Vector In Gene Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Lentiviral Vector In Gene Therapy Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Lentiviral Vector In Gene Therapy Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Lentiviral Vector In Gene Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Lentiviral Vector In Gene Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Lentiviral Vector In Gene Therapy Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Lentiviral Vector In Gene Therapy Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Lentiviral Vector In Gene Therapy Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Lentiviral Vector In Gene Therapy Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Lentiviral Vector In Gene Therapy Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Lentiviral Vector In Gene Therapy Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Lentiviral Vector In Gene Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Lentiviral Vector In Gene Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Lentiviral Vector In Gene Therapy Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Lentiviral Vector In Gene Therapy Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Lentiviral Vector In Gene Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Lentiviral Vector In Gene Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Lentiviral Vector In Gene Therapy Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Lentiviral Vector In Gene Therapy Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Lentiviral Vector In Gene Therapy Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Lentiviral Vector In Gene Therapy Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Lentiviral Vector In Gene Therapy Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Lentiviral Vector In Gene Therapy Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Lentiviral Vector In Gene Therapy Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Lentiviral Vector In Gene Therapy Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Lentiviral Vector In Gene Therapy Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Lentiviral Vector In Gene Therapy Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Lentiviral Vector In Gene Therapy Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Lentiviral Vector In Gene Therapy Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Lentiviral Vector In Gene Therapy Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Lentiviral Vector In Gene Therapy Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Lentiviral Vector In Gene Therapy Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Lentiviral Vector In Gene Therapy Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Thermo Fisher Scientific Sirion-Biotech GmbH Corporation Information
    Table 107. Thermo Fisher Scientific Sirion-Biotech GmbH Description and Major Businesses
    Table 108. Thermo Fisher Scientific Sirion-Biotech GmbH Lentiviral Vector In Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 109. Thermo Fisher Scientific Sirion-Biotech GmbH Lentiviral Vector In Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Thermo Fisher Scientific Sirion-Biotech GmbH Recent Developments
    Table 111. Vigene Biosciences Corporation Information
    Table 112. Vigene Biosciences Description and Major Businesses
    Table 113. Vigene Biosciences Lentiviral Vector In Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 114. Vigene Biosciences Lentiviral Vector In Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Vigene Biosciences Recent Developments
    Table 116. OriGene Technologies Corporation Information
    Table 117. OriGene Technologies Description and Major Businesses
    Table 118. OriGene Technologies Lentiviral Vector In Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 119. OriGene Technologies Lentiviral Vector In Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. OriGene Technologies Recent Developments
    Table 121. SignaGen Laboratories Corporation Information
    Table 122. SignaGen Laboratories Description and Major Businesses
    Table 123. SignaGen Laboratories Lentiviral Vector In Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 124. SignaGen Laboratories Lentiviral Vector In Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. SignaGen Laboratories Recent Developments
    Table 126. Takara Bio Corporation Information
    Table 127. Takara Bio Description and Major Businesses
    Table 128. Takara Bio Lentiviral Vector In Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 129. Takara Bio Lentiviral Vector In Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Takara Bio Recent Developments
    Table 131. Cell Biolabs Corporation Information
    Table 132. Cell Biolabs Description and Major Businesses
    Table 133. Cell Biolabs Lentiviral Vector In Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 134. Cell Biolabs Lentiviral Vector In Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Cell Biolabs Recent Developments
    Table 136. GenTarget Corporation Information
    Table 137. GenTarget Description and Major Businesses
    Table 138. GenTarget Lentiviral Vector In Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 139. GenTarget Lentiviral Vector In Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. GenTarget Recent Developments
    Table 141. GENEMEDI Corporation Information
    Table 142. GENEMEDI Description and Major Businesses
    Table 143. GENEMEDI Lentiviral Vector In Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 144. GENEMEDI Lentiviral Vector In Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. GENEMEDI Recent Developments
    Table 146. Bluebird Bio Corporation Information
    Table 147. Bluebird Bio Description and Major Businesses
    Table 148. Bluebird Bio Lentiviral Vector In Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 149. Bluebird Bio Lentiviral Vector In Gene Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Bluebird Bio Recent Developments
    Table 151. Key Raw Materials Lists
    Table 152. Raw Materials Key Suppliers Lists
    Table 153. Lentiviral Vector In Gene Therapy Distributors List
    Table 154. Lentiviral Vector In Gene Therapy Customers List
    Table 155. Lentiviral Vector In Gene Therapy Market Trends
    Table 156. Lentiviral Vector In Gene Therapy Market Drivers
    Table 157. Lentiviral Vector In Gene Therapy Market Challenges
    Table 158. Lentiviral Vector In Gene Therapy Market Restraints
    Table 159. Research Programs/Design for This Report
    Table 160. Key Data Information from Secondary Sources
    Table 161. Key Data Information from Primary Sources
List of Figures
    Figure 1. Lentiviral Vector In Gene Therapy Product Picture
    Figure 3. Global Lentiviral Vector In Gene Therapy Market Share by Type in 2021 & 2028
    Figure 3. Retrovirus (RV) Product Picture
    Figure 4. Adenovirus (AdV) Product Picture
    Figure 5. Adeno-associated Virus (AAV) Product Picture
    Figure 6. Global Lentiviral Vector In Gene Therapy Market Share by Application in 2021 & 2028
    Figure 7. Hospital
    Figure 8. Clinic
    Figure 9. Research Institution
    Figure 10. Others
    Figure 11. Lentiviral Vector In Gene Therapy Report Years Considered
    Figure 12. Global Lentiviral Vector In Gene Therapy Sales 2017-2028 (K Units)
    Figure 13. Global Lentiviral Vector In Gene Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Lentiviral Vector In Gene Therapy Revenue 2017-2028 (US$ Million)
    Figure 15. Global Lentiviral Vector In Gene Therapy Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Lentiviral Vector In Gene Therapy Sales Market Share by Region (2017-2022)
    Figure 17. Global Lentiviral Vector In Gene Therapy Sales Market Share by Region (2023-2028)
    Figure 18. North America Lentiviral Vector In Gene Therapy Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Lentiviral Vector In Gene Therapy Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Lentiviral Vector In Gene Therapy Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Lentiviral Vector In Gene Therapy Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Lentiviral Vector In Gene Therapy Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Lentiviral Vector In Gene Therapy Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Lentiviral Vector In Gene Therapy Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Lentiviral Vector In Gene Therapy Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Lentiviral Vector In Gene Therapy Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Lentiviral Vector In Gene Therapy Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Lentiviral Vector In Gene Therapy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Lentiviral Vector In Gene Therapy in the World: Market Share by Lentiviral Vector In Gene Therapy Revenue in 2021
    Figure 30. Global Lentiviral Vector In Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Lentiviral Vector In Gene Therapy Sales Market Share by Type (2017-2028)
    Figure 32. Global Lentiviral Vector In Gene Therapy Revenue Market Share by Type (2017-2028)
    Figure 33. Global Lentiviral Vector In Gene Therapy Sales Market Share by Application (2017-2028)
    Figure 34. Global Lentiviral Vector In Gene Therapy Revenue Market Share by Application (2017-2028)
    Figure 35. North America Lentiviral Vector In Gene Therapy Sales Market Share by Type (2017-2028)
    Figure 36. North America Lentiviral Vector In Gene Therapy Revenue Market Share by Type (2017-2028)
    Figure 37. North America Lentiviral Vector In Gene Therapy Sales Market Share by Application (2017-2028)
    Figure 38. North America Lentiviral Vector In Gene Therapy Revenue Market Share by Application (2017-2028)
    Figure 39. North America Lentiviral Vector In Gene Therapy Sales Share by Country (2017-2028)
    Figure 40. North America Lentiviral Vector In Gene Therapy Revenue Share by Country (2017-2028)
    Figure 41. U.S. Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Lentiviral Vector In Gene Therapy Sales Market Share by Type (2017-2028)
    Figure 44. Europe Lentiviral Vector In Gene Therapy Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Lentiviral Vector In Gene Therapy Sales Market Share by Application (2017-2028)
    Figure 46. Europe Lentiviral Vector In Gene Therapy Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Lentiviral Vector In Gene Therapy Sales Share by Country (2017-2028)
    Figure 48. Europe Lentiviral Vector In Gene Therapy Revenue Share by Country (2017-2028)
    Figure 49. Germany Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 50. France Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Lentiviral Vector In Gene Therapy Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Lentiviral Vector In Gene Therapy Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Lentiviral Vector In Gene Therapy Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Lentiviral Vector In Gene Therapy Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Lentiviral Vector In Gene Therapy Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Lentiviral Vector In Gene Therapy Revenue Share by Region (2017-2028)
    Figure 60. China Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 63. India Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Lentiviral Vector In Gene Therapy Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Lentiviral Vector In Gene Therapy Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Lentiviral Vector In Gene Therapy Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Lentiviral Vector In Gene Therapy Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Lentiviral Vector In Gene Therapy Sales Share by Country (2017-2028)
    Figure 75. Latin America Lentiviral Vector In Gene Therapy Revenue Share by Country (2017-2028)
    Figure 76. Mexico Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Lentiviral Vector In Gene Therapy Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Lentiviral Vector In Gene Therapy Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Lentiviral Vector In Gene Therapy Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Lentiviral Vector In Gene Therapy Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Lentiviral Vector In Gene Therapy Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Lentiviral Vector In Gene Therapy Revenue Share by Country (2017-2028)
    Figure 85. Turkey Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 87. UAE Lentiviral Vector In Gene Therapy Revenue (2017-2028) & (US$ Million)
    Figure 88. Lentiviral Vector In Gene Therapy Value Chain
    Figure 89. Lentiviral Vector In Gene Therapy Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
INQUIRE FOR DISCOUNT
HAVE A QUERY?
INQUIRE ABOUT REPORT EMAIL US
OUR CUSTOMER
Bioinformatics Barcelona
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global RNA and DNA Extraction Kit Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36Z8348
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global DNA Library Preparation Kits Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-5U6259
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Edible Insects Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20A9325
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global DNA Repair Proteins And Reagents Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-9S9524
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICIES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions